Full data on the vaccine, developed by Oxford University and the Astrogenica Group, have been submitted to a British regulator, Health Minister Matt Hancock announced on Wednesday, paving the way for soon-to-be certification.
“I am pleased to announce that the Oxford AstraZeneca vaccine developed here in the UK has submitted all its data to the MHRA,” the UK regulator said, “for approval,” he said in a statement. Press conference.
“This is the next step in deciding on the expansion of the vaccine, which is already being made here in the UK,” he said. Restoration in southern England and identification of another new strain of the virus among travelers from South Africa.
The United Kingdom has already approved the first vaccine, developed by Pfizer and BioMtech, already deployed since the beginning of this month, especially among the most vulnerable individuals. The government said more than 500,000 people had already received their first dose.
Those from Oxford and AstraZeneca are eagerly awaiting because large-scale deployment is less difficult and does not need to be kept at such a low temperature.